Bloodletting is the practice of deliberately removing blood from the body to treat or prevent disease. For over 2,000 years it was one of the most common medical procedures in the world, based on a theory of health that turned out to be wrong. But the practice never fully disappeared. Modern medicine still uses a controlled form of bloodletting to treat a handful of specific conditions where removing blood genuinely helps.
The Theory Behind the Ancient Practice
The ancient Greek physician Galen taught that the body contained four vital fluids called humors: blood, phlegm, yellow bile, and black bile. Health depended on keeping these four in balance. If one humor built up in excess, you got sick. The remedy was straightforward: remove the excess. Too much bile meant taking a purgative. Too much blood meant opening a vein.
This framework dominated Western medicine for roughly 1,500 years. Bloodletting wasn’t a fringe treatment or a folk remedy. It was the standard of care, prescribed for fevers, infections, inflammation, and dozens of other conditions. Physicians believed that draining blood reduced overstimulation in the body and calmed the inflammation driving illness. The logic was internally consistent, even if the underlying biology was completely wrong.
How It Was Done
Practitioners used several tools depending on the situation. The simplest was a lancet, a small, sharp blade used to nick a vein directly. For more controlled cuts, doctors turned to scarificators, spring-loaded brass devices that made multiple small incisions at once. One improved design could make sixteen little cuts in the skin in a single snap. These were widely used across Europe well into the second half of the 1800s.
Leeches offered what was considered a gentler alternative. A physician would place several leeches on the skin near the affected area. The animals could locate tiny blood vessel networks beneath the surface before biting, and their suction drew blood from the surrounding tissue. The major drawback was imprecision. After removing the leeches, there was no reliable way to measure how much blood had actually been taken. In the early 1800s, demand for medicinal leeches was so enormous that shortages became a serious problem across Europe, prompting inventors to build mechanical substitutes. One 1817 design used a vacuum pump with interchangeable heads and adjustable lancets, allowing doctors to control both the depth of the wound and the amount of blood drawn.
Why Medicine Abandoned It
The turning point came in the 1830s, when a French physician named Pierre-Charles-Alexandre Louis did something radical for the time: he counted. Louis tracked 77 pneumonia patients and grouped them by whether they had been bled early in their illness (days one through four) or later (days five through nine). Patients bled early did recover about three days faster on average, which seemed to support the practice. But 44% of the early-bleeding group died, compared to just 25% of those bled later.
Louis called the result “startling and apparently absurd.” He didn’t reject bloodletting entirely, but he concluded its usefulness was far narrower than anyone had assumed, limited at best to severe cases involving important organs. His work, published as a book in 1835 and translated into English the following year, was one of the first attempts to evaluate a medical treatment using actual patient data rather than theory. It helped launch a slow but decisive shift away from bloodletting as a general-purpose therapy.
Conditions Treated With Bloodletting Today
Modern medicine calls the procedure therapeutic phlebotomy. It looks a lot like a standard blood donation: a needle in the arm, a bag collecting about a pint of blood, and the whole thing usually finished in under an hour. It remains an approved treatment for three main conditions.
Hereditary Hemochromatosis
This is the most common reason for therapeutic phlebotomy today. People with hemochromatosis absorb too much iron from food, and the excess accumulates in organs like the liver, heart, and pancreas, eventually causing serious damage. Since red blood cells contain iron, removing blood forces the body to use up its iron stores when building replacement cells. The goal is to bring a blood protein called ferritin, which reflects iron storage, down to between 50 and 100 nanograms per milliliter. Getting there can take several years of weekly sessions. Once levels are in range, most people only need blood drawn three to four times a year to stay on target.
Polycythemia Vera
In this condition, the bone marrow produces too many red blood cells, thickening the blood and raising the risk of clots, stroke, and heart attack. Phlebotomy is considered the cornerstone of treatment. The target is keeping hematocrit, the percentage of blood volume occupied by red cells, below 45% in men and below 42% in women. During pregnancy, the target drops to below 35%, since the fetus will still receive sufficient iron even at those lower levels.
Porphyria Cutanea Tarda
This condition causes painful skin blistering and fragility, driven by a buildup of certain compounds called porphyrins. Excess iron in the body worsens the problem. Regular blood removal reduces iron stores, and within one to eight months (four months on average), porphyrin levels in the urine drop enough that skin symptoms begin clearing up. Levels often continue improving even after treatment stops. The approach works regardless of whether the patient has iron overload or normal iron levels, and even in patients who continue drinking alcohol, which is a known trigger.
Leeches in Modern Surgery
Medicinal leeches also made a quiet comeback. The FDA approved them as a medical device for plastic and reconstructive surgery in 2004. Surgeons use them after procedures like tissue flap transfers or finger reattachments, where tiny veins may not yet be reconnected and blood pools dangerously in the reattached tissue. Leeches relieve that congestion, buying time for the body’s own blood vessels to heal and restore normal drainage. Their saliva contains natural blood-thinning compounds that keep blood flowing from the bite site even after the leech is removed.
Risks of Therapeutic Phlebotomy
For the modern version, side effects are uncommon and generally mild. A prospective study tracking 587 phlebotomy procedures found that adverse events occurred in less than 5% of sessions. The most typical reaction was a vasovagal episode, the lightheaded, woozy feeling some people get during or after a blood draw. None of the reactions in that study were clinically serious, and all were managed on-site by nursing staff with full recovery. The overall risk profile is comparable to what healthy blood donors experience, and even older patients or those with other health conditions tolerate the procedure safely when it’s carefully managed.
The main long-term concern is iron deficiency if sessions are too frequent or ferritin levels aren’t monitored. For patients with hemochromatosis, that’s actually the mechanism of treatment. For others, doctors track iron levels to make sure they don’t overshoot.